Sorafenib is active on lung metastases from synovial sarcoma

Ann Oncol. 2009 Feb;20(2):386-7. doi: 10.1093/annonc/mdn685.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzenesulfonates / therapeutic use*
  • Humans
  • Lung Neoplasms / complications*
  • Lung Neoplasms / diagnostic imaging
  • Lung Neoplasms / secondary*
  • Male
  • Middle Aged
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / therapeutic use*
  • Radiography
  • Sarcoma, Synovial / drug therapy*
  • Sarcoma, Synovial / pathology
  • Sarcoma, Synovial / secondary*
  • Sorafenib
  • Time Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib